Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases
- PMID: 25100403
- PMCID: PMC4312882
- DOI: 10.1002/bies.201400094
Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases
Abstract
Synthetic biology is an emerging engineering discipline that attempts to design and rewire biological components, so as to achieve new functions in a robust and predictable manner. The new tools and strategies provided by synthetic biology have the potential to improve therapeutics for neurodegenerative diseases. In particular, synthetic biology will help design small molecules, proteins, gene networks, and vectors to target disease-related genes. Ultimately, new intelligent delivery systems will provide targeted and sustained therapeutic benefits. New treatments will arise from combining 'protect and repair' strategies: the use of drug treatments, the promotion of neurotrophic factor synthesis, and gene targeting. Going beyond RNAi and artificial transcription factors, site-specific genome modification is likely to play an increasing role, especially with newly available gene editing tools such as CRISPR/Cas9 systems. Taken together, these advances will help develop safe and long-term therapies for many brain diseases in human patients.
Keywords: artificial cell systems; genome editing; neurodegeneration; synthetic proteins.
© 2014 The Authors. Bioessays published by WILEY Periodicals, Inc.
Figures
References
-
- Reardon S. Brain-mapping projects to join forces. Nat News. 2014 doi: . - DOI
-
- Thies W, Bleiler L, Alzheimer's A. 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 2013;9:208–45. - PubMed
-
- Wittchen HU, Jacobi F, Rehm J, Gustavsson A. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79. , et al. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
